CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78) is an indazole-3-carboxamide based synthetic cannabinoid that has been sold online as a designer drug. It is a potent agonist for cannabinoid receptors CB1 and CB2, with in vitro EC50 values of 0.58 nM and 6.12 nM, respectively. In mice, CUMYL-4CN-BINACA produces hypothermic and pro-convulsant effects via the CB1 receptor,[7] and anecdotal reports suggest it has an active dose of around 0.1 mg in humans.
CUMYL-4CN-BINACA is metabolized to produce cyanide, raising concerns about liver toxicity. There is one reported case of hyperthermia, rhabdomyolysis, and kidney failure associated with its use.
Reviews
There are no reviews yet.